University of Southern California

Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C.  In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.

Friday September 24, 2027

NEW ADVANCES IN METABOLIC DISEASES

ACPE# TBA

Objectives:

1.  Describe how the treatment paradigm for obesity has shifted from lifestyle-only approaches to disease-modifying pharmacotherapy.

2.  Explain the updated terminology from NAFLD/MASH TO MASLD/MASH.

3.  Summarize major therapeutic advances in MASH, including resmetirom and semaglutide.

4.  Discuss how obesity therapies are changing cardiovascular disease prevention.

5.  Identify emerging areas: incretin combinations, lipid-lowering therapies, Lp(a), anti-inflammatory therapy, biomarkers, and precision metabolic medicine.

————————————————————————————————–

Saturday September 25, 2027

EVOLVING TREATMENTS FOR HIV: PATHWAY TO VIRAL ERADICATION

ACPE# TBA

Objectives:

1.  Explain how antiretroviral therapy, or ART, suppresses HIV but does not eliminate latent reservoirs.

2.  Describe major advances in HIV treatment, including integrase inhibitor-based regimens, long-acting injectables, and capsid inhibitors.

3.  Distinguish between viral suppression, functional cure, and sterilizing cure.

4.  Summarize current HIV cure strategies, including latency reversal, immune-based therapy, broadly neutralizing antibodies, gene editing, and stem cell approaches.

5.  Discuss scientific, clinical, and ethical barriers to HIV eradication.

————————————————————————————————–

Sunday September 26, 2027

CHRONIC CNS INFLAMMATION

ACPE# TBA

Objectives:

1.  Define chronic CNS inflammation and distinguish it from acute protective inflammation.

2.  Identify the major cellular players involved: microglia, astrocytes, neurons, oligodendrocytes, endothelial cells, and peripheral immune cells.

3.  Explain how chronic inflammation contributes to neurodegeneration, demyelination, synaptic dysfunction, and blood-brain barrier breakdown.

4.  Compare CNS inflammatory mechanisms across diseases such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, ALS, traumatic brain injury, and aging.

5.  Discuss emerging biomarkers, imaging methods, and therapeutic strategies targeting neuroinflammation.